Bavarian Nordic
Bavarian Nordic is a leading biotechnology company specializing in the research, development, and manufacturing of innovative vaccines and immunotherapies. With a strong focus on infectious diseases and cancer, Bavarian Nordic leverages advanced proprietary technologies to deliver effective solutions for public health and biodefense. The company’s robust pipeline includes vaccines for smallpox, monkeypox, and other emerging infectious diseases, supporting global health preparedness. Committed to quality and scientific excellence, Bavarian Nordic collaborates with governments, healthcare organizations, and industry partners worldwide to address unmet medical needs and improve patient outcomes through cutting-edge vaccine development and production.
